SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clover Health is experiencing a significant surge driven by a successful court ruling that led to a CMS-mandated recalculation of its 2026 Medicare Advantage star rating from 3.5 to 4.5 stars. Community sentiment is highly optimistic, with investors actively discussing this re-rating as a major valuation catalyst that validates the company's AI-driven technology stack and its Counterpart Health business model.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing heightened volatility and investor frustration as the stock faces downward pressure despite potential in its obesity pipeline, with the community actively debating whether managements slow clinical execution and lack of a buyout justifies the current discounted valuation. Investors remain deeply divided between those holding for long-term clinical catalysts, specifically upcoming maintenance trial data, and those growing weary of the stock's persistent underperformance against broader biotech gains.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intensifying geopolitical friction in the Middle East and ongoing debates regarding the company's valuation and merger outlook. Community discussions are highly polarized, centering on the impact of military escalations on the broader market, criticisms of executive leadership, and deep skepticism from investors regarding the stock's long-term viability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant downward pressure as investors react to a massive $7 billion equity and convertible note offering, which many fear will lead to substantial shareholder dilution. While management insists the capital is essential to fulfill an unexpected $39 billion surge in AI server orders, the community remains deeply divided between those labeling the company a poorly managed risk and those viewing the sell-off as a strategic buying opportunity for long-term growth.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility and aggressive institutional positioning as investors closely watch its cloud adoption and AI infrastructure demand ahead of the company's upcoming earnings report. The community remains divided between those expecting a major breakout driven by robust backlog growth and those bracing for a potential sell-off if results fail to exceed lofty expectations.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility driven by escalating geopolitical tensions involving Iran and uncertainty surrounding upcoming high-profile IPOs. The community is actively debating the impact of these macro headwinds, with many traders expressing frustration over rapid intraday price swings and conflicting reports regarding potential military escalations.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following a positive quarterly earnings report and a series of strategic collaborations with aerospace and energy companies that underscore its critical role in advanced manufacturing. The community is actively discussing the stock's role in the SpaceX supply chain and potential squeeze dynamics driven by high short interest and anticipation surrounding future contract updates.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is seeing intense community discussion driven by its role as a critical power provider for data centers, with investors weighing high valuation concerns against its massive backlog and validation from hyperscaler partnerships. Many are actively comparing the stock's trajectory to other infrastructure plays as they debate if the current price levels reflect sustainable AI-driven demand or an overextended growth narrative.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is facing significant downward pressure following disappointing quarterly earnings that missed revenue estimates and saw a sharp decline in comparable store sales, compounded by lowered annual guidance. The community is actively debating the effectiveness of management's turnaround efforts, with many retail investors expressing frustration over declining foot traffic and the brand's recent struggles to balance its core identity with rebranding initiatives.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors digest the recent selection of HARMONi-6 data for a prestigious ASCO plenary session, a move widely interpreted by the community as a major de-risking signal for the company's lead candidate, ivonescimab. While community sentiment remains divided between those expecting a potential short squeeze and those concerned about the company's cash burn and reliance on clinical data derived from Chinese trials, the stock continues to see high volume as traders position themselves ahead of upcoming survival data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taking profits on my Bio/Pharma positions - $XBI, $XPH extended 

Stocktwits

SPDR S&P Biotech ETF

SPDR Pharmaceuticals ETF

Taking profits on my Bio/Pharma positions - 